For more information on Age-Related Macular Degeneration go to the NHS website. If you've had a diagnosis, in addition to ...

INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the ...

Macular degeneration is a leading cause of vision loss for people over 50, but there are ways to help protect your eyesight.

Study from Case Western Reserve University and VA Northeast Ohio Healthcare System examines genetic risk profiles across ...

BEDFORD, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced upcoming ...

InMed Pharmaceuticals (INM) announced the selection of an intravitreal, IVT, formulation for INM-089 as a drug candidate to be utilized in the ...

Older adults who participated in time-restricted fasting by skipping breakfast were not at reduced risk for glaucoma compared ...

Dry Age-Related Macular Degeneration Market The healthcare landscape in 2025 is poised for a transformative shift, driven by innovation and ...

The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...

INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the projected therapeutic level, indicating a favorable pharmacokinetic profile and a ...